Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics

Data Last Updated

Bills & Votes: 1 hour ago
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR4605Referred to Committee

End Prescription Drug Ads Now Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-22
Introduced
2
Cosponsors
HR
ⓘ
Type

Sponsor

Jerrold Nadler
Jerrold Nadler
Democrat · NY · Representative
Votes with party: 98.5% (538 recorded votes)

Full profile: /officials/N000002

Source: Congress.gov · FEC

Cosponsors (2)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

2 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-07-22

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2025-07-22

Plain-English Summary

The proposal would ban pharmaceutical companies from advertising prescription drugs directly to consumers on television, radio, and online platforms. Currently, drug makers spend billions of dollars on ads encouraging people to ask their doctors about specific medications, but this bill would eliminate that advertising while still allowing ads for over-the-counter drugs and medical devices. The change would primarily affect pharmaceutical companies' marketing budgets and could reduce the number of medication requests patients bring to their doctors' appointments.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR8522PROTECT Act
    Referred to Committee · 2026-04-27
  • HR8226Helicopter Safety Parity Act of 2026
    Referred to Committee · 2026-04-09
  • HR5068MORE Act
    Referred to Committee · 2026-01-13
  • HRES985Expressing opposition to the use of onychectomy, also known as declawing, for elective surgery in cats.
    Referred to Committee · 2026-01-13